Demant A/S
Demant A/S (WILYY) Stock Overview
Explore Demant A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
9.2B
P/E Ratio
24.71
EPS (TTM)
$1.02
ROE
0.25%
WILYY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Demant A/S (WILYY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $18.72.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.71 and a market capitalization of 9.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment provides headsets for collaborative work and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Søren Nielsen
19,917
Kongebakken 9, Smørum
2011